Investors centre

Our innovative line of patent-protected products provides both economic and environmental benefits for our customers and capitalises upon long-term trends towards natural systems and biological solutions to promote plant health and growth.

Key figures

Revenue ($’000)

$8,128

2017; $7,685

Cash and investments ($'000)

$4,284

2017; $3,894

Gross profit margin

64.9%

2017; 61.6%

Stock exchange announcements

Investment case.svg

Investment case

Find out how our business model, strategy and established capabilities support our clear investment proposition.

Read more